The series followed the widespread toxic contamination of HIV drug, Viracept, in June 2007. Over the series it emerged that in fact every batch of the drug manufactured since 1998 had been contaminated, thanks to inadequate controls during production. Regulators also exclusively admitted to in-PharmaTechnologist.com that many other drugs on the market could also be tainted with similar toxic compounds.
